RNS Number : 2499I
Marlowe PLC
23 November 2018
 

23 November 2018

 

Marlowe plc

New debt facility

Marlowe plc ("Marlowe" or the "Group"), the support services group focused on acquiring and developing companies that provide critical testing and maintenance services, has signed a new, enlarged revolving credit facility with HSBC and National Westminster Bank.

The new facility replaces the Group's existing £18 million facilities and comprises a three-year, £30 million revolving credit facility and an additional accordion facility of £15 million.

At 30 September 2018 Marlowe had net cash of £4.9 million.

The enlarged debt facility will provide further resources to support the Group's acquisition-led growth strategy.

The Group will publish its Half Year results for the period ended 30 September 2018 on 4 December 2018.

For further information:

 

Marlowe plc

www.marloweplc.com

 

 

Alex Dacre, Chief Executive

Tel: +44 (0) 203 813 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

 

 

Nicholas Wells

Tel: +44 (0)20 7397 8900

 

 

FTI Consulting

 

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

     

 

About Marlowe plc

Marlowe is an AIM-listed company formed to create sustainable shareholder value through the acquisition and development of businesses that provide critical testing & maintenance services in the UK.  It is focused on fire protection, security systems, water treatment and air quality services - which are essential to its customers' operations and invariably governed by regulation, and where customers require a single specialist outsourced provider with nationwide coverage. Our customers can be found on most high streets, in office complexes and industrial estates, and include SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGBCGUPRGCP